Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus: Sema-Lit

NCT06060392 is registered in ClinicalTrials.gov with Medanta, The Medicity, India as lead sponsor.

NCT NCT06060392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06060392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus: Sema-Lit
Lead sponsor
Medanta, The Medicity, India
Phase
Not applicable
Overall status
Recruiting
Start date
October 30, 2023
Completion date
November 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus, liver transplant; complications